| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Gabriel Rodrigo Fries, Sarwar Khan, Sydney Stamatovich, Elena Dyukova, Consuelo Walss-Bass, Scott D Lane, Joy M Schmitz, Margaret C Wardl. Anhedonia in cocaine use disorder is associated with inflammatory gene expression. PloS one. vol 13. issue 11. 2019-04-22. PMID:30408130. |
treatments for cocaine use disorder (cud) are variably effective, and there are no fda-approved medications. |
2019-04-22 |
2023-08-13 |
human |
| Maenia Scarpino, Giovanni Lanzo, Maya Salimova, Francesco Lolli, Amedeo Del Vecchio, Cesarina Cossu, Maria Bastianelli, Brunella Occupati, Cecilia Lanzi, Stefano Pallanti, Aldo Amantini, Guido Mannaioni, Antonello Gripp. Efficacy of high-frequency (15Hz) repetitive transcranial magnetic stimulation (rTMS) of the left premotor cortex/dorsolateral prefrontal cortex in decreasing cocaine intake (the MagneTox study): A study protocol for a randomized placebo-controlled pilot trial. Neurophysiologie clinique = Clinical neurophysiology. vol 49. issue 1. 2019-04-04. PMID:30712533. |
cocaine use disorder (cud) is very common and has psychological and physical consequences. |
2019-04-04 |
2023-08-13 |
Not clear |
| Marek Schwendt, John Shallcross, Natalie A Hadad, Mark D Namba, Helmut Hiller, Lizhen Wu, Eric G Krause, Lori A Knacksted. A novel rat model of comorbid PTSD and addiction reveals intersections between stress susceptibility and enhanced cocaine seeking with a role for mGlu5 receptors. Translational psychiatry. vol 8. issue 1. 2019-04-01. PMID:30291225. |
ptsd is highly comorbid with cocaine use disorder (cud), and cocaine users with ptsd + cud are more resistant to treatment. |
2019-04-01 |
2023-08-13 |
rat |
| Matthias Kirschner, Ronald Sladky, Amelie Haugg, Philipp Stämpfli, Elisabeth Jehli, Martina Hodel, Etna Engeli, Sarah Hösli, Markus R Baumgartner, James Sulzer, Quentin J M Huys, Erich Seifritz, Boris B Quednow, Frank Scharnowski, Marcus Herdene. Self-regulation of the dopaminergic reward circuit in cocaine users with mental imagery and neurofeedback. EBioMedicine. vol 37. 2019-03-12. PMID:30377073. |
enhanced drug-related reward sensitivity accompanied by impaired sensitivity to non-drug related rewards in the mesolimbic dopamine system are thought to underlie the broad motivational deficits and dysfunctional decision-making frequently observed in cocaine use disorder (cud). |
2019-03-12 |
2023-08-13 |
Not clear |
| John Marsden, Camille Goetz, Tim Meynen, Luke Mitcheson, Garry Stillwell, Brian Eastwood, John Strang, Nick Gre. Memory-Focused Cognitive Therapy for Cocaine Use Disorder: Theory, Procedures and Preliminary Evidence From an External Pilot Randomised Controlled Trial. EBioMedicine. vol 29. 2018-09-05. PMID:29478874. |
cocaine use disorder (cud) is a debilitating condition with no nice-recommended medication or specific psychosocial interventions. |
2018-09-05 |
2023-08-13 |
Not clear |
| Andrea L Dimet, Irma E Cisneros, Robert G Fox, Sonja J Stutz, Noelle C Anastasio, Kathryn A Cunningham, Kelly T Dinele. A Protocol for Measuring Cue Reactivity in a Rat Model of Cocaine Use Disorder. Journal of visualized experiments : JoVE. issue 136. 2018-08-24. PMID:29985329. |
cocaine use disorder (cud) follows a trajectory of repetitive self-administration during which previously neutral stimuli gain incentive value. |
2018-08-24 |
2023-08-13 |
human |
| Joy M Schmitz, Charles E Green, Khader M Hasan, Jessica Vincent, Robert Suchting, Michael F Weaver, F Gerard Moeller, Ponnada A Narayana, Kathryn A Cunningham, Kelly T Dineley, Scott D Lan. PPAR-gamma agonist pioglitazone modifies craving intensity and brain white matter integrity in patients with primary cocaine use disorder: a double-blind randomized controlled pilot trial. Addiction (Abingdon, England). vol 112. issue 10. 2018-06-01. PMID:28498501. |
pioglitazone (pio), a potent agonist of ppar-gamma, is a promising candidate treatment for cocaine use disorder (cud). |
2018-06-01 |
2023-08-13 |
Not clear |
| Joy M Schmitz, Charles E Green, Khader M Hasan, Jessica Vincent, Robert Suchting, Michael F Weaver, F Gerard Moeller, Ponnada A Narayana, Kathryn A Cunningham, Kelly T Dineley, Scott D Lan. PPAR-gamma agonist pioglitazone modifies craving intensity and brain white matter integrity in patients with primary cocaine use disorder: a double-blind randomized controlled pilot trial. Addiction (Abingdon, England). vol 112. issue 10. 2018-06-01. PMID:28498501. |
we tested the effects of pio on targeted mechanisms relevant to cud: cocaine craving and brain white matter (wm) integrity. |
2018-06-01 |
2023-08-13 |
Not clear |
| P Araos, Esperanza Vergara-Moragues, Francisco González-Saiz, María Pedraz, Nuria García-Marchena, Pablo Romero-Sanchiz, Juan Jesus Ruiz, Rafael Campos-Cloute, Antonia Serrano, Francisco Javier Pavón, Marta Torrens, Fernando Rodriguez De Fonsec. Differences in the Rates of Drug Polyconsumption and Psychiatric Comorbidity among Patients with Cocaine Use Disorders According to the Mental Health Service. Journal of psychoactive drugs. vol 49. issue 4. 2018-05-30. PMID:28682218. |
the degree of severity of cocaine use disorders (cud) is greater in the tc population. |
2018-05-30 |
2023-08-13 |
Not clear |
| Elise E DeVito, Aryeh I Herman, Noah S Konkus, Huiping Zhang, Mehmet Sofuogl. Atomoxetine in abstinent cocaine users: Cognitive, subjective and cardiovascular effects. Pharmacology, biochemistry, and behavior. vol 159. 2018-05-21. PMID:28716656. |
no pharmacotherapies are approved for the treatment of cocaine use disorders (cud). |
2018-05-21 |
2023-08-13 |
human |
| Amie C Hayley, Con Stough, Luke A Downe. DSM-5 cannabis use disorder, substance use and DSM-5 specific substance-use disorders: Evaluating comorbidity in a population-based sample. European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology. vol 27. issue 8. 2018-04-18. PMID:28663122. |
current dsm-5 cud was similarly associated with increased incidence of a range of dsm-5 suds and was independently associated with concurrently reporting current dsm-5; sedative (adjusted or= 5.1, 95%ci 2.9-9.0), cocaine (aor= 9.3, 95%ci 5.6-15.5), stimulant (aor= 4.3, 95%ci 2.3-7.9), club drug (aor= 16.1, 95%ci 6.3-40.8), opioid (aor= 4.6, 95%ci 3.0-6.8) and alcohol-use disorder (aor= 3.0, 95%ci 2.5-3.7); but not heroin or 'other' drug use disorder (both p>0.05). |
2018-04-18 |
2023-08-13 |
Not clear |
| Lesia M Ruglass, Alina Shevorykin, Christina Brezing, Mei-Chen Hu, Denise A Hie. Demographic and clinical characteristics of treatment seeking women with full and subthreshold PTSD and concurrent cannabis and cocaine use disorders. Journal of substance abuse treatment. vol 80. 2018-04-02. PMID:28755772. |
women with full or subthreshold ptsd and co-occurring cannabis use disorder (cud) and cocaine use disorder (cod; n=99) were compared to their counterparts with co-occurring cud only (n=26) and co-occurring cod only (n=161) on rates of trauma exposure, psychiatric disorders, psychosocial problems, and other substance use utilizing a set of multivariate logistic regressions. |
2018-04-02 |
2023-08-13 |
Not clear |
| Muhammad A Parvaz, Scott J Moeller, Pias Malaker, Rajita Sinha, Nelly Alia-Klein, Rita Z Goldstei. Abstinence reverses EEG-indexed attention bias between drug-related and pleasant stimuli in cocaine-addicted individuals. Journal of psychiatry & neuroscience : JPN. vol 42. issue 2. 2018-01-08. PMID:28245173. |
in this study we used the late positive potential (lpp) to investigate whether such increased attention bias toward drug-related relative to non-drug-related cues changes over a protracted period of reduced drug use in treatment-seeking individuals with a cocaine use disorder (cud). |
2018-01-08 |
2023-08-13 |
Not clear |
| Mehmet Sofuoglu, James Poling, Theresa Babuscio, Kishorchandra Gonsai, Kevin Severino, Charla Nich, Kathleen M Carrol. Carvedilol does not reduce cocaine use in methadone-maintained cocaine users. Journal of substance abuse treatment. vol 73. 2017-12-14. PMID:28017186. |
the goal of this study was too test the efficacy of carvedilol (car), an adrenergic blocker, for reducing cocaine use in individuals with cocaine use disorder (cud). |
2017-12-14 |
2023-08-13 |
Not clear |
| James J Mahoney, Colin N Haile, Richard De La Garza, Harsh Thakkar, Thomas F Newto. Electrocardiographic characteristics in individuals with cocaine use disorder. The American journal on addictions. vol 26. issue 3. 2017-09-22. PMID:28248441. |
the objective of this study was to further characterize baseline heart rate and electrocardiograph (ecg) profiles of individuals with cocaine use disorder (cud) by evaluating demographic and drug use variables that may impact cardiovascular profiles. |
2017-09-22 |
2023-08-13 |
Not clear |
| Hazem E Hassan, Deanna Kelly, Moshe Honick, Sagar Shukla, Ahmed Ibrahim, David A Gorelick, Matthew Glassman, Robert P McMahon, Heidi J Wehring, Ann Marie Kearns, Stephanie Feldman, Mingming Yu, Ken Bauer, Jia Bei Wan. Pharmacokinetics and Safety Assessment of l-Tetrahydropalmatine in Cocaine Users: A Randomized, Double-Blind, Placebo-Controlled Study. Journal of clinical pharmacology. vol 57. issue 2. 2017-08-16. PMID:27363313. |
cocaine use disorder (cud) remains a significant public health challenge. |
2017-08-16 |
2023-08-13 |
human |
| James J Mahoney, Ari D Kalechstein, Anthony P De Marco, Thomas F Newton, Richard De La Garz. The relationship between premorbid IQ and neurocognitive functioning in individuals with cocaine use disorders. Neuropsychology. vol 31. issue 3. 2017-08-09. PMID:28054825. |
to determine whether premorbid iq mediates performance on neurocognitive tests in individuals diagnosed with cocaine use disorder (cud). |
2017-08-09 |
2023-08-13 |
Not clear |
| Chiara Rapinesi, Antonio Del Casale, Simone Di Pietro, Vittoria Rachele Ferri, Daria Piacentino, Gabriele Sani, Ruggero Nessim Raccah, Abraham Zangen, Stefano Ferracuti, Alessandro Emiliano Vento, Gloria Angeletti, Roberto Brugnoli, Georgios D Kotzalidis, Paolo Girard. Add-on high frequency deep transcranial magnetic stimulation (dTMS) to bilateral prefrontal cortex reduces cocaine craving in patients with cocaine use disorder. Neuroscience letters. vol 629. 2017-06-29. PMID:27365134. |
the aim of this study is to evaluate the effect of high frequency deep transcranial magnetic stimulation (dtms) on craving in patients with cocaine use disorder (cud). |
2017-06-29 |
2023-08-13 |
Not clear |
| Natalie A Hadad, Lizhen Wu, Helmut Hiller, Eric G Krause, Marek Schwendt, Lori A Knacksted. Conditioned stress prevents cue-primed cocaine reinstatement only in stress-responsive rats. Stress (Amsterdam, Netherlands). vol 19. issue 4. 2017-05-18. PMID:27181613. |
neurobiological mechanisms underlying comorbid posttraumatic stress disorder (ptsd) and cocaine use disorder (cud) are unknown. |
2017-05-18 |
2023-08-13 |
rat |
| Anna B Konova, Scott J Moeller, Dardo Tomasi, Rita Z Goldstei. Effects of chronic and acute stimulants on brain functional connectivity hubs. Brain research. vol 1628. issue Pt A. 2016-09-27. PMID:25721787. |
nineteen individuals with cocaine use disorders (cud) and 15 healthy controls completed resting-state fmri scans following a randomly assigned dose of methylphenidate (mph; 20mg) or placebo. |
2016-09-27 |
2023-08-13 |
human |